← Open Payments lookup

JOHN CARR: Open Payments

NPI 1013643873 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$580 in 23 payments from 9 companies in 2025. Trend: 2023 $549 · 2024 $258 · 2025 $580

Food & beverage: $580
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$146
Neurocrine BioSciences, Inc.5$121
Teva Pharmaceuticals USA, Inc.5$107
Otsuka America Pharmaceutical, Inc.3$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
ABBVIE INC.3$47
Otsuka Pharmaceutical Development & Commercialization, Inc.1$21
Corium, LLC1$17
Vanda Pharmaceuticals Inc.1$14

Products named: SPRAVATO, INGREZZA, AUSTEDO XR, REXULTI, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across ID — which companies pay providers there.